Literature DB >> 29846785

Clinical features of different orbital manifestations of granulomatosis with polyangiitis.

D S Ismailova1, J V Abramova2, P I Novikov3, Y O Grusha2,4.   

Abstract

PURPOSE: The aim of this study was to distinguish different forms of orbital involvement in granulomatosis with polyangiitis (GPA) and to compare their clinical course and outcomes.
METHODS: Two hundred twenty-six consecutive patients with GPA were retrospectively studied. All patients fulfilled the classification criteria of American College of Rheumatology; diagnosis of localized GPA was established according to Chapel Hill Consensus. Of those, 74 patients with orbital disease were enrolled into further investigation of different forms of orbital disease.
RESULTS: Overall ocular involvement was diagnosed in 50% (113/226) of patients; in 5.3% (12/226), inflammatory eye disease resulted in permanent visual loss. Most common ophthalmic manifestations were orbital masses, episcleritis/conjunctivitis, and scleritis (74/226, 32/226, and 12/226, respectively). Seventy-four patients with orbital involvement were divided into three groups: those with orbital mass without primary lacrimal gland involvement (1st group, 45 patients), those with lacrimal gland involvement (2nd group, 26 patients), and those with extraocular myositis (3rd group, 3 patients). Symptoms such as orbital pain, decreased vision, double vision, red eye, scleritis, orbital wall destruction, primary gaze strabismus, and ocular motility restriction were significantly more common in the 1st group. Peripheral ulcerative keratitis (PUK) was present in the 1st group only. Patients of the 1st group suffered from visual loss, double vision, primary gaze strabismus, and ocular motility restriction significantly more often. Eleven of them developed visual loss; 5 of them underwent enucleation, whereas in the group of patients with dacryoadenitis, only 1 patient had BCVA less than 0.3.
CONCLUSIONS: Three types of orbital disease in GPA were proposed: orbital mass without primary lacrimal gland involvement, dacryoadenitis, and extraocular myositis. Patients with orbital mass without lacrimal gland involvement are characterized with a higher rate of systemic disease, severe clinical course not uncommonly associated with other ophthalmic manifestations (necrotizing scleritis, PUK, orbital walls destruction), relatively unfavorable outcome with high level of morbidity (optic nerve atrophy, anophthalmos, strabismus), and higher rate of recurrences. Dacryoadenitis in GPA showed to be not severe manifestation with favorable prognosis.

Entities:  

Keywords:  Dacryoadenitis; Granulomatosis with polyangiitis; Myositis; Ophthalmic manifestations; Orbital mass

Mesh:

Year:  2018        PMID: 29846785     DOI: 10.1007/s00417-018-4014-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

Review 1.  [Ophthalmologic manifestations of Wegener's granulomatosis].

Authors:  T N Kiseleva; A A Polunina
Journal:  Vestn Oftalmol       Date:  2008 Jan-Feb

2.  EULAR recommendations for the management of primary small and medium vessel vasculitis.

Authors:  C Mukhtyar; L Guillevin; M C Cid; B Dasgupta; K de Groot; W Gross; T Hauser; B Hellmich; D Jayne; C G M Kallenberg; P A Merkel; H Raspe; C Salvarani; D G I Scott; C Stegeman; R Watts; K Westman; J Witter; H Yazici; R Luqmani
Journal:  Ann Rheum Dis       Date:  2008-04-15       Impact factor: 19.103

Review 3.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

Review 4.  Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature.

Authors:  Pierre-Raphaël Rothschild; Christian Pagnoux; Raphaele Seror; Antoine P Brézin; Emmanuelle Delair; Loïc Guillevin
Journal:  Semin Arthritis Rheum       Date:  2012-12-24       Impact factor: 5.532

5.  Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage.

Authors:  Julia U Holle; Christopher Voigt; Marcus Both; Konstanze Holl-Ulrich; Bernhard Nölle; Martin Laudien; Frank Moosig; Wolfgang L Gross
Journal:  Rheumatology (Oxford)       Date:  2013-01-04       Impact factor: 7.580

Review 6.  Superior oblique myositis as an early feature of orbital Wegener's granulomatosis.

Authors:  Aysha Salam; George Meligonis; R Malhotra
Journal:  Orbit       Date:  2008

7.  Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients.

Authors:  K O Devaney; W D Travis; G Hoffman; R Leavitt; R Lebovics; A S Fauci
Journal:  Am J Surg Pathol       Date:  1990-06       Impact factor: 6.394

8.  Lacrimal gland enlargement as one of the ocular manifestations of Wegener's granulomatosis.

Authors:  R J Boukes; W A de Vries-Knoppert
Journal:  Doc Ophthalmol       Date:  1985-01-31       Impact factor: 2.379

Review 9.  Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee.

Authors:  G Anderson; E T Coles; M Crane; A C Douglas; A R Gibbs; D M Geddes; E T Peel; J B Wood
Journal:  Q J Med       Date:  1992-06

10.  Orbital involvement by Wegener's granulomatosis: imaging findings.

Authors:  J M Provenzale; S Mukherji; N B Allen; M Castillo; A W Weber
Journal:  AJR Am J Roentgenol       Date:  1996-04       Impact factor: 3.959

View more
  6 in total

Review 1.  Extraocular muscle enlargement.

Authors:  Khizar Rana; Valerie Juniat; Sandy Patel; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-17       Impact factor: 3.535

Review 2.  Autoimmune disease of head and neck, imaging, and clinical review.

Authors:  Alireza Paydar; Zachary B Jenner; Tyrell J Simkins; Yu-Ming Chang; Lotfi Hacein-Bey; Arzu Ozturk; Andrew Birkeland; Reza Assadsangabi; Osama Raslan; Ghazal Shadmani; Michelle Apperson; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2022-05-22

3.  Granulomatosis with polyangiitis-associated ischemic optic neuropathy in a previously healthy 50-year-old female.

Authors:  Michael S Quist; Paramjit K Bhullar; Landon C Meekins; Divakar Gupta
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-15

4.  Atypical painless vision loss in a patient with granulomatosis with polyangiitis.

Authors:  Patricia C Nelson; Vamsi Kunam; Claudia Prospero Ponce
Journal:  GMS Ophthalmol Cases       Date:  2020-12-15

Review 5.  Therapy of ocular complications in ANCA+ associated vasculitis.

Authors:  Simion Macarie Sorin; Mihăilă Răzvan-Marian; Mariana Macarie Daniela; Toc Dan-Alexandru
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

Review 6.  ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review.

Authors:  David Faz-Muñoz; Andrea Hinojosa-Azaola; Juan M Mejía-Vilet; Norma O Uribe-Uribe; Marina Rull-Gabayet; Wallace Rafael Muñoz-Castañeda; Nancy Janeth Vargas-Parra; Eduardo Martín-Nares
Journal:  Immunol Res       Date:  2022-04-21       Impact factor: 4.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.